Nigeria: Nigeria Among High-Volume Markets for New $1 HIV, Syphilis, Hepatitis B Testing Bundle
[Premium Times] The companies said their analysis identified Nigeria, Ethiopia, Tanzania, Uganda, Kenya, Mozambique and South Africa among the countries with the largest potential markets for antenatal hepatitis B screening.
The new $1 testing bundle for HIV, syphilis, and hepatitis B is set to expand screening in Nigeria, as identified by analysis from Premier Medical Corporation and Impact Nexus Africa. This package, which combines two rapid diagnostic tests for $1 per woman, aims to reach high-volume markets such as Nigeria, Ethiopia, Tanzania, Uganda, Kenya, Mozambique, and South Africa.
If adopted, the bundle could generate $215 million in commodity savings across 74 low- and middle-income countries between 2026 and 2035. In Nigeria specifically, only 12.3% of pregnant women were tested for hepatitis B in the 2026 Demographic and Health Survey, highlighting the potential impact of this affordable screening option.
Written by urgent.news from AllAfrica Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
